ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.600
-0.080 (-4.76%)
At close: Sep 25, 2026, 4:00 PM EDT
1.650
+0.050 (3.12%)
After-hours: Sep 25, 2026, 7:56 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $483.72 million as of September 25, 2026. Its market cap has decreased by -39.57% in one year.
Market Cap
483.72M
Enterprise Value
305.68M
1-Year Change
-39.57%
Ranking
Category
Stock Price
$1.60
ChartMarket Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $483.72M, an increase of 86.91%. That is a compound annual growth rate of 12.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 483.70M | -28.22% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 512.98M |
| Puma Biotechnology | 504.33M |
| Arvinas | 496.28M |
| Autolus Therapeutics | 493.73M |
| REGENXBIO | 488.50M |
| Capricor Therapeutics | 486.04M |
| Assembly Biosciences | 481.94M |
| Entera Bio | 475.27M |